Browsing by Author VICTOR NURCOMBE

Select a letter below to browse by last name or type
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


Showing results 8 to 26 of 26 < previous 
Issue DateTitleAuthor(s)
2007Glycosaminoglycan and growth factor mediated murine calvarial cell proliferationManton, K.J.; Haupt, L.M.; Vengadasalam, K.; Nurcombe, V. ; Cool, S.M. ; Manton, K.J.
2009Glycosaminoglycan composition changes with MG-63 osteosarcoma osteogenesis in vitro and induces human mesenchymal stem cell aggregationKumarasuriyar, A.; Murali, S.; Nurcombe, V. ; Cool, S.M. 
2007Heparan sulfate regulates the anabolic activity of MC3T3-E1 preosteoblast cells by induction of Runx2Jackson, R.A.; Murali, S.; Nurcombe, V. ; Cool, S.M. ; Van, Wijnen A.J.; Stein, G.S.
2006Heparan sulfate regulation of progenitor cell fateCool, S.M. ; Nurcombe, V. 
2007In vitro biocompatibility and bioactivity of microencapsulated heparan sulfateLuong-Van, E.; Nurcombe, V. ; Cool, S. ; Grondahl, L.
2007Isolation of a native osteoblast matrix with a specific affinity for BMP2Grunert, M.; Dombrowski, C.; Sadasivam, M.; Manton, K.; Cool, S.M. ; Nurcombe, V. 
2006Long-term loading inhibits ERK1/2 phosphorylation and increases FGFR3 expression in MC3T3-E1 osteoblast cellsJackson, R.A.; Kumarasuriyar, A.; Nurcombe, V. ; Cool, S.M. 
2007Osteogenic differentiation of murine embryonic stem cells is mediated by fibroblast growth factor receptorsKee, W.N.; Speicher, T.; Dombrowski, C.; Helledie, T.; Haupt, L.M.; Nurcombe, V. ; Cool, S.M. 
2007Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) composite biomaterials for bone tissue regeneration: In vitro performance assessed by osteoblast proliferation, osteoclast adhesion and resorption, and macrophage proinflammatory responseCool, S.M. ; Kenny, B.; Nurcombe, V. ; Wu, A.; Trau, M.; Grondahl, L.; Cassady, A.I.
2007Regulated expression of syndecan-4 in rat calvaria osteoblasts induced by fibroblast growth factor-2Song, S.J.; Cool, S.M. ; Nurcombe, V. 
2007Selection using the alpha-1 integrin (CD49a) enhances the multipotentiality of the mesenchymal stem cell population from heterogeneous bone marrow stromal cellsRider, D.A.; Nalathamby, T.; Nurcombe, V. ; Cool, S.M. 
2006Sulfated glycosaminoglycans mediate the effects of FGF2 on the osteogenic potential of rat calvarial osteoprogenitor cellsLing, L.; Murali, S.; Dombrowski, C.; Haupt, L.M.; Nurcombe, V. ; Cool, S.M. ; Stein, G.S.; Van, Wijnen A.J.
2007Sustained release and osteogenic potential of heparan sulfate-doped fibrin glue scaffolds within a rat cranial modelWoodruff, M.A. ; Rath, S.N.; Susanto, E.; Hutmacher, D.W. ; Haupt, L.M.; Nurcombe, V. ; Cool, S.M. 
2007Temporal and functional changes in glycosaminoglycan expression during osteogenesisNurcombe, V. ; Goh, F.J.; Haupt, L.M.; Murali, S.; Cool, S.M. 
2006Temporal expression of proteoglycans in the rat limb during bone healingSong, S.J.; Nurcombe, V. ; Cool, S.M. ; Hutmacher, D. 
2007The in vivo assessment of a novel scaffold containing heparan sulfate for tissue engineering with human mesenchymal stem cellsLuong-Van, E.; Song, S.; Nurcombe, V. ; Cool, S. ; Grondahl, L.
Sep-2005The osteoblast-heparan sulfate axis: Control of the bone cell lineageCool, S.M. ; Nurcombe, V. 
2006The use of heparan sulfate to augment fracture repair in a rat fracture modelJackson, R.A.; Nurcombe, V. ; Cool, S.M. ; McDonald, M.M.; Little, D.G.
2009Wnt signaling controls the fate of mesenchymal stem cellsLing, L.; Nurcombe, V. ; Cool, S.M.